rhodamine 123 has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alzpodien, J; Anastassiou, G; Brevis Nunez, F; Buer, J; Duensing, S; Ganser, A; Grosse, J; Meyer, N; Nasarek, A; Probst, M | 1 |
| Anttila, M; Braybrooke, JP; Ellmén, J; Ganesan, TS; Harris, AL; Houlbrook, S; Rockett, H; Talbot, DC; Vallis, KA | 1 |
1 trial(s) available for rhodamine 123 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Resistance, Multiple; Female; Fluorescent Dyes; Humans; Kidney Neoplasms; Male; Middle Aged; Orosomucoid; Protein Binding; Rhodamine 123; Tamoxifen; Toremifene; Vinblastine | 2000 |
1 other study(ies) available for rhodamine 123 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Renal Cell; Cell Adhesion; Drug Resistance, Neoplasm; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Kidney Neoplasms; Neoplasm Proteins; Receptors, Very Late Antigen; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Vinblastine | 1996 |